ITGA2 and breast cancer: Additionally, the ITGA2 BglII polymorphism has been associated with increased risk for higher disease stages of breast cancer (32), positive history for oral cancer (33), and prevalence of diabetic retinopathy, myocardial infarction, and stroke (34–36).